טוען...
Isavuconazole: Mechanism of Action, Clinical Efficacy, and Resistance
Increasing incidence of invasive fungal infections combined with a growing population of immunocompromised hosts has created a rising need for antifungal agents. Isavuconazole, a second-generation broad-spectrum triazole with activity against yeasts, dimorphic fungi, and molds, has a favorable safet...
שמור ב:
| הוצא לאור ב: | J Fungi (Basel) |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7712939/ https://ncbi.nlm.nih.gov/pubmed/33260353 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jof6040324 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|